Phase 2 Mpox Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa
Mpox (Monkeypox)
BioNTech SE310 enrolled6 locationsNCT07379580
Recruiting
Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Monkeypox (Mpox)
Bavarian Nordic744 enrolled10 locationsNCT07199569
Recruiting
Phase 2
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC
Mpox (Monkeypox)
Institute of Tropical Medicine, Belgium600 enrolled1 locationNCT06839989